Evidence map›Paper›PMID 42327901›Full record

ArticleFrontiers in pediatrics2026

Risk factors for severe

Di Hu, Yingqian Zhang, Ran Ma, Chunxiao Ba, Peijuan Wang

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Di HuGraduate School, Hebei Medical University, Shijiazhuang, Hebei, China.
Yingqian ZhangDepartment No. 3 of Respiratory Medicine, Hebei Children's Hospital, Shijiazhuang, Hebei, China.
Ran MaGraduate School, Hebei Medical University, Shijiazhuang, Hebei, China.
Chunxiao BaGraduate School, Hebei Medical University, Shijiazhuang, Hebei, China.
Peijuan WangGraduate School, Hebei Medical University, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate the clinical characteristics of Methods: A total of 133 children with CPP were retrospectively enrolled from Hebei Children's Hospital between 2023 and 2025. Disease severity was classified according to the Guidelines for the Management of Community-Acquired Pneumonia in Children (2024 revision), and patients were divided into a non-severe group ( Results: Compared with the non-severe group, children in the severe group had a higher peak temperature and longer duration of fever (both Conclusion: Decreased lymphocyte percentage and elevated serum IgA are associated with severe CPP in children, suggesting potential roles in risk stratification. Further multicenter prospective studies are warranted to validate and confirm these findings.

Indexed as

childrenChlamydia pneumoniae pneumoniaimmunoglobulin arisk factorssevere pneumonia

Identifiers

PMID42327901
PMCPMC13276858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.